Q32 Bio Inc.
QTTB
$1.94
$0.052.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.30M | -59.79M | -47.73M | -60.61M | -57.05M |
| Total Depreciation and Amortization | 453.00K | 483.00K | 487.00K | 491.00K | 492.00K |
| Total Amortization of Deferred Charges | 196.00K | 213.00K | 194.00K | 175.00K | 132.00K |
| Total Other Non-Cash Items | 5.41M | 4.74M | -11.03M | -10.78M | -5.27M |
| Change in Net Operating Assets | -7.84M | -11.29M | -9.64M | 3.73M | 30.12M |
| Cash from Operations | -54.08M | -65.65M | -67.72M | -67.00M | -31.58M |
| Capital Expenditure | -60.00K | -75.00K | -75.00K | -73.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.00M | 19.90M | 20.00M | 20.00M | 10.00M |
| Cash from Investing | 9.94M | 19.83M | 19.93M | 19.93M | 9.98M |
| Total Debt Issued | -53.16M | 0.00 | 7.00M | 60.16M | 65.66M |
| Total Debt Repaid | 8.71M | 0.00 | 0.00 | -8.71M | -13.91M |
| Issuance of Common Stock | 1.31M | 1.69M | 43.69M | 43.45M | 42.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.44M | -5.90M | 44.44M | 0.00 | 0.00 |
| Cash from Financing | 1.31M | -4.21M | 95.14M | 94.90M | 94.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.83M | -50.03M | 47.35M | 47.82M | 72.61M |